Rare Entities of Mixed Phenotypic Acute Leukemia: Are They Really So Rare? Largest Series of B+T MPAL

  • Dr Raghavendra H .V. Associate Professor of Pathology, Kidwai Memorial Institute of Oncology Bangalore, Karnataka, India
  • Dr Namrata N R Assistant Professor of Pathology, Kidwai Memorial Institute of Oncology Bangalore, Karnataka, India
  • Dr Vijay C. Raghu Assistant Professor, Department Biostatistics, Kidwai Memorial Institute of Oncology Bangalore, Karnataka, India
  • Dr Lakshmiah K Chinnagiriyappa Prof & head Department of Medical Oncology, Kidwai Memorial Institute of Oncology Bangalore, Karnataka, India
DOI: https://doi.org/10.17511/ijmrr.2016.i03.21
Keywords: Acute leukemias of ambiguous lineage, Mixed phenotypic acute leukemia, aberrant antigens, Lymphoid, cytogenetics, Flow immunophenotyping, MCP 841 Protocol

Abstract

Background: MPAL are rare, accounts 4% of acute leukemias. B+T MPAL are extremely rare. There is no robust information on the clinical and biologic features of these leukemias. Present study from kidwai memorial institute of oncology focused on MPAL rare types, especially B+T MPAL.

Design and Methods: We attempted to classify MPAL, based on WHO 2008 classification and attempted to summarise diagnostic criteria, cytochemistry, immunophenotyping, cytogenetics & clinical features of B+T MPAL.

Results: Most MPAL cases reported were B/Myeloid, followed by B+T MPAL, T+Myeloid , undifferentiated and unclassifiable leukemias respectively.

Conclusion: Among MPAL unusual high incidence of B+T MPAL (38.4%) was noted. Overall median survival was 5 years.

Downloads

Download data is not yet available.

References

1. Bene MC, Porwit A .Acute leukemias of ambiguous lineage Semin Diagn Pathol, 2012 Feb;29(1): 12-8. [PubMed]

2. Borowitz M J Bene MC, HarrisNL, PorwitA, Matutes E Acute leukemia of ambiguous lineage: WHO classification of hematopoietic and lymphoid tissue 4th ed.IARC, Lyon, France:2008.pp 150-155.

3. Ludwig, W.d.,Haferlach,T.&Schoch,C(2003)Classification of Acute Leukaemias:PerspectiveI. Humana Press Inc., Totowa, NJ.

4. Tseih Sun .Mixed phenotypic acute leukemia: In Flow cytometry ,immunohistochemistry and molecular genetics for hematologic neoplasms: 2nd edition. wolters kluwer/Lippincott Williams & wilkins,Phildelphia.2012;chapter 16:168-173.

5. Sameer kulkarni, Michael Lill and Dimitrios Tzachanis .HSOA Journal of Hematology.Blood transfusion and Disorders.JHematolBloodTransfus Disord2014;vol1:issue1.

6. EstellaMatutes,RicardoMorilla,NahlaFarahat,FelixCarbonell,JohnSwansbury,Martin Dyer,Daniel Catovsky . Recent Advances in the cyto biology of Leukemias,Definition of Acute BiphenotypicLeukemia.Haematologica 1997; 82(1):64-66.

7. Renu Sukumaran, Rekha A Nair, Priya Mary Jacob, Kunjulekshmi Ammaraveen drannair Anila, Shruthy Prem, Rajeshwary Binitha et al .Flowcytometry analysis of Mixed phenotype acute leukemia: Experience from a tertiary oncology center.Indian Journal of Pathology and Microbiology.June 2015;58(2).

8. Heidrun Gerr, Martin Zimmermann, MartinSchrappe, Michael Dworzak, Wolf-Dieter Ludwig, Jutta Bradtke, Anja Moericke, Richard Schabathetal. Acuteleukemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations; British journal of hematology.2010;149(1),84-92. doi 10.1111/j1365-2141.2009.08058/epub2010jan18. [PubMed]

9. Zhang YM1, Wu DP, Sun AN et al. Study on the clinical characteristics of 32 patients with mixed phenotype acute leukemia. ZhonghuaXue Ye XueZaZhi. 2011 Jan;32(1):12-6. [PubMed]

10. Gujral S, Polampalli S, BadrinathY, Kumar A, SubramanianPG,Raje G, et al.Clinico-hematological profile in biphenotypic acute leukemia.Indian Journal of Cancer, April-June, 2009; Vol. 46: No. 2pp. 160-168.

11. Kohla SA1, sabbagh AA 1,Omri H E 2,Ibrahim F A1,Otazu I B3,Alhajri H3Yassin M A .Mixed Phenotype Acute Leukemia with Two Immunophenotypically Distinct B and T Blasts Populations,DoublePh(+) Chromosome and complex Karyotype.Report of an Unusal Case .Clin Med Insights Blood Disord.2015 sept 21;
8:25-31. doi:10.4137/CMBD.s24631.c collection 2015.

12. April EstellaMatutes, Winfried FPicki, Marsvan,’ Veer, Ricardo Morilla, John Swansbury, Herbert Strobletal Mixed- phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification.Blood.2011;volume 117,no11,3163-3171.doi:10.1182/blood-2010-10-314682. [PubMed]

13. O K Weinberg and DA Arber .Mixed –Phenotype acute leukemia :historical overview and a new definition. Leukemia 2010;24:1844-1851. [PubMed]

14. Lingzhi Yan, Nana Ping, Mingging Zhu, Aining Sun, Yongquan Xue, Changgeng Ruanetal.Clinicalimmunophenotypic, Cytogenetic, And Molecular Genetic Features In 117 Adult Patients With Mixed-Phenotype Acute Leukemia Defined By WHO-2008 Classification.Haematologica November 2012 ; 97: 1708-1712.
Rare Entities of Mixed Phenotypic Acute Leukemia: Are They Really So Rare? Largest Series of B+T MPAL
CITATION
DOI: 10.17511/ijmrr.2016.i03.21
Published: 2016-03-31
How to Cite
1.
H .V. R, N R N, C. Raghu V, K Chinnagiriyappa L. Rare Entities of Mixed Phenotypic Acute Leukemia: Are They Really So Rare? Largest Series of B+T MPAL. Int J Med Res Rev [Internet]. 2016Mar.31 [cited 2024Apr.26];4(3):401-6. Available from: https://ijmrr.medresearch.in/index.php/ijmrr/article/view/490
Issue
Vol 4 No 3 (2016): MARCH
Section
Original Article

Most read articles by the same author(s)